Difference between revisions of "Team:Sheffield/episode7"

Line 345: Line 345:
 
<div class = "jumbotron">
 
<div class = "jumbotron">
 
                         <h2>RAPID</h2>
 
                         <h2>RAPID</h2>
 +
                  <img src="https://static.igem.org/mediawiki/2016/1/1f/T--Sheffield--RAPID1.jpg">
 +
                  <img src="https://static.igem.org/mediawiki/2016/5/59/T--Sheffield--RAPID2.jpg">
 +
 
<p>We attended a patient panel at a local hospital named the Research Advisory Panel for Infectious Diseases (RAPID. This panel has a focus on infectious diseases and sets up a dialogue between patients and clinicians, with a view to gaining a more personal perspective of antibiotic usage. </p>
 
<p>We attended a patient panel at a local hospital named the Research Advisory Panel for Infectious Diseases (RAPID. This panel has a focus on infectious diseases and sets up a dialogue between patients and clinicians, with a view to gaining a more personal perspective of antibiotic usage. </p>
  

Revision as of 14:10, 18 October 2016

A template page

PATIENTS

From our human practices research, we could really see the scale of antibiotic resistance as a problem. We have gained perspectives from doctors, we would like to do the same with patients who have had experience with antibiotics.

RAPID

We attended a patient panel at a local hospital named the Research Advisory Panel for Infectious Diseases (RAPID. This panel has a focus on infectious diseases and sets up a dialogue between patients and clinicians, with a view to gaining a more personal perspective of antibiotic usage.

One member of the panel said that generally patients want a pill; especially if they feel ill and think that they need something to help them feel better. Another panel member said that her husband never finished a course of antibiotics - he would take them until he felt better and then he would stop. If he then got ill again he would start taking the rest of the antibiotics, this was because of a no-waste attitude towards the antibiotics.

From our discussions we perceived that the general public’s understanding of antibiotic use was lacking and that this has been a driving force for misuse of antibiotics.

Antibiotic resistance is a major problem because it diminishes the effectiveness of antibiotics. However, we are not always mindful of how much we need effective antibiotics. We would like to know on a more personal level of the impact of antibiotic resistance, so we interviewed Mr. Paul Slater. He has been suffering from vancomycin-resistant enterococci. Paul's’ story shows us to the damage that antibiotic resistance can do. We hope his story will raise awareness on this pressing problem.